Rheumatology | Oxford Academic Authors interested in publishing in Rheumatology may be able to publish their paper Open Access using funds available through their institution’s agreement with OUP Find out if your institution is participating
Issues | Rheumatology - Oxford Academic Executive Summary: The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs
About | Rheumatology - Oxford Academic Rheumatology strives to support global research and discovery by publishing the highest quality scientific papers covering the full breadth of rheumatology, from hypothesis-generating basic results to translational and clinical research, as well as adult, adolescent, and paediatric conditions
General Instructions | Rheumatology - Oxford Academic Providing high-quality publishing for over 70 years, Rheumatology is an international, peer-reviewed journal covering the full breadth of rheumatology, from hypothesis-generating basic results to clinical research
Guidelines | Rheumatology - Oxford Academic All BSR guidelines are published in Rheumatology under an open access license or made free to access We also publish guidelines from other organisations Browse the latest guideline papers below
British Society for Rheumatology guideline for the management of foot . . . The guideline was developed in line with the British Society for Rheumatology Guidelines Protocol (version 5 4, November 2023) A lay summary of this guideline can be found in Supplementary File S1, available at Rheumatology online Background
2025 British Society for Rheumatology guideline for the treatment of . . . This guideline is for health professionals in the UK who directly care for adults with axSpA (including but not limited to rheumatologists, rheumatology specialist nurses, allied health professionals, rheumatology specialty trainees, pharmacists), people living with axSpA and other stakeholders
Rheumatology in China: challenges and development It plays an important role in the development of rheumatology in this country as well as in the Asia-Pacific League of Associations for Rheumatology One of the CRA’s key tasks over the past 30 years has been to quantify the burden of rheumatic diseases in China
Enhancing current guidance for psoriatic arthritis and its . . . The TLR was performed within Medline, through PubMed and Embase; 10 725 records were identified, with 174 studies being selected for full-text review following the application of the exclusion criteria (Supplementary Fig S2, available at Rheumatology online)